InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (25 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
25
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Gao Hanlin, Chief Scientific Officer. Director active across 1 company, notably Fulgent Genetics, Inc.. Aggregated, 67 disclosures have been published. Split: 0 buy · 25 sells. Total volume traded: €476k. History available since 30 April 2021. The latest transaction was disclosed on 26 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Gao Hanlin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations67 total
1,645 shares@ US$19.67Common StockSEC:0001193125-26-321085:0
945 shares@ US$17.600.0028% mcap1.4% of flowCommon StockSEC:0001684532-26-000003:0
1,645 shares@ US$16.310.0044% mcap2.3% of flowCommon StockSEC:0001193125-26-187451:0
897 shares@ US$24.760.0042% mcap8.3% of flowCommon StockSEC:0001684532-26-000001:0
403 shares@ US$23.010.7% of flowCommon StockSEC:0001193125-26-072639:0
1,331 shares@ US$27.532.7% of flowCommon StockSEC:0001193125-26-027405:0
1,075 shares@ US$28.33182.4% of flowCommon StockSEC:0001193125-25-306920:0
943 shares@ US$29.56952.2% of flowCommon StockSEC:0001193125-25-304293:0
535 shares@ US$30.4731.3% of flowCommon StockSEC:0001193125-25-297321:0
1,642 shares@ US$23.743.2% of flowCommon StockSEC:0001193125-25-253873:0
1,063 shares@ US$22.02672.0% of flowCommon StockSEC:0001684532-25-000014:0
943 shares@ US$21.48471.7% of flowCommon StockSEC:0001684532-25-000010:0
548 shares@ US$21.50161.0% of flowCommon StockSEC:0001684532-25-000005:0
1,642 shares@ US$18.372.7% of flowCommon StockSEC:0000950170-25-099791:0
754 shares@ US$20.29081.4% of flowCommon StockSEC:0000950170-25-081048:0
383 shares@ US$20.57530.6% of flowCommon StockSEC:0000950170-25-078346:0
656 shares@ US$20.51691.0% of flowCommon StockSEC:0000950170-25-078346:1
79 shares@ US$17.350.1% of flowCommon StockSEC:0000950170-25-062886:0
1,157 shares@ US$18.881.9% of flowCommon StockSEC:0000950170-25-060278:0
985 shares@ US$15.451.5% of flowCommon StockSEC:0000950170-25-032772:0
3,384 shares0Common StockSEC:0000950170-25-029435:0
417 shares@ US$16.460.7% of flowCommon StockSEC:0000950170-25-026884:0
90 shares@ US$17.000.1% of flowCommon StockSEC:0000950170-25-012439:0
1,329 shares@ US$17.212.2% of flowCommon StockSEC:0000950170-25-009841:0
1,373 shares@ US$19.49992.6% of flowCommon StockSEC:0000950170-24-133308:0
25 of 67 declarations
About Gao Hanlin
Gao Hanlin is Chief Scientific Officer at Fulgent Genetics, Inc. The declarant has 64 filings in total, and across the sampled recent filings from 2021-05-03 to 2026-05-28, the sell amount is EUR 457531, with the most frequent transaction nature being Tax withholding.
